Status:
COMPLETED
Near-Infrared Spectroscopy for Blood Glucose Measurements
Lead Sponsor:
InLight Solutions
Collaborating Sponsors:
Luminous Medical
Conditions:
Healthy
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this study is to evaluate the performance of a near-infrared transmission measurement in blood samples collected from healthy volunteers. We propose that NIR spectroscopic blood glucose...
Detailed Description
Luminous Medical is developing an automated glucose measurement system that addresses the rapidly growing clinical demand for tight glycemic control in the intensive care unit (ICU), operating room (O...
Eligibility Criteria
Inclusion
- Males and females between the ages of 18 and 65
- Healthy
- Not currently pregnant
- Hematocrit \>38%
Exclusion
- Pregnancy (Self Reported)
- Females that have given birth 6 weeks prior (self reported)
- Anemia (hematocrit \<38%) Hematocrit is checked via a capillary fingerstick and a blood hematocrit reader.
- Under the age of 18 or over the age of 65.
- Diagnosed with Type I or II Diabetes (Self-Reported).
- Donated blood (\>25 mls) in the last 8 weeks
- Heart rate \>100 beats per minute
- Weigh less than 110 lbs.
- Currently taking anticoagulants (ex: coumadin)
- Abnormal blood pressure (diastolic \>90)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01168115
Start Date
January 1 2008
End Date
December 1 2008
Last Update
July 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
InLight Solutions
Albuquerque, New Mexico, United States, 87106